Gilead Sciences
GILD
#96
Rank
A$262.81 B
Marketcap
A$211.83
Share price
-1.04%
Change (1 day)
23.26%
Change (1 year)

Gilead Sciences (GILD) - Cash on Hand

Cash on Hand as of September 2025 : A$10.39 Billion

According to Gilead Sciences's latest financial reports the company has A$10.39 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Gilead Sciences - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$18.59 B74.43%
2023-12-31A$10.66 B13.63%
2022-12-31A$9.38 B4.33%
2021-12-31A$8.99 B-6.65%
2020-12-31A$9.63 B-72.3%
2019-12-31A$34.78 B-18.57%
2018-12-31A$42.71 B30.71%
2017-12-31A$32.67 B98.01%
2016-12-31A$16.50 B-17.7%
2015-12-31A$20.05 B62.02%
2014-12-31A$12.37 B417.76%
2013-12-31A$2.39 B33.38%
2012-12-31A$1.79 B-81.44%
2011-12-31A$9.65 B367.34%
2010-12-31A$2.06 B12.01%
2009-12-31A$1.84 B-27.3%
2008-12-31A$2.53 B89.27%
2007-12-31A$1.34 B12.8%
2006-12-31A$1.18 B-62.37%
2005-12-31A$3.15 B94.9%
2004-12-31A$1.62 B70.37%
2003-12-31A$0.95 B-43.13%
2002-12-31A$1.67 B46.46%
2001-12-31A$1.14 B24.5%
2000-12-31A$0.91 B104.75%
1999-12-31A$0.44 B171.33%
1998-12-31A$0.16 B236.16%
1997-12-31A$49.11 M-70.44%
1996-12-31A$0.16 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
A$28.42 B 173.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$21.18 B 103.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$8.01 B-22.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$10.27 B-1.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.35 B 28.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$5.39 B-48.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$2.30 B-77.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$8.88 B-14.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$25.75 B 147.84%๐Ÿ‡บ๐Ÿ‡ธ USA